Candida albicans due to the phenotypic similarity between the two species. Prospective screening of oral rinses from 63 HIV-infected patients detected atypical dark green isolates on CHROMagar Candida compared to typical C. albicans isolates, which are light green. Forty-eight atypical isolates and three control strains were characterized by germ tube formation, differential growth at 37, 42, and 45°C, identification by API 20C, fluorescence, chlamydoconidium production, and fingerprinting by Ca3 probe DNA hybridization patterns. All isolates were germ tube positive. Very poor or no growth occurred at 42°C with 22 of 51 isolates. All 22 poorly growing isolates at 42°C and one isolate with growth at 42°C showed weak hybridization of the Ca3 probe with genomic DNA, consistent with C. dubliniensis identification. No C. dubliniensis isolate but only 18 of 28 C. albicans isolates grew at 45°C. Other phenotypic or morphologic tests were less reliable in differentiating C. dubliniensis from C. albicans. Antifungal susceptibility testing showed fluconazole MICs ranging from <0.125 to 64 g/ml. Two isolates were resistant to fluconazole (MIC, 64 g/ml) and one strain was dose dependent susceptible (MIC, 16 g/ml). MICs of other azoles, including voriconazole, itraconazole, and SCH 56592, for these isolates were lower. C. dubliniensis was identified in 11 of 63 (17%) serially evaluated patients. Variability in phenotypic characteristics dictates the use of molecular and biochemical techniques to identify C. dubliniensis. This study identifies C. dubliniensis in HIV-infected patients from San Antonio, Tex., and shows that C. dubliniensis is frequently detected in those patients by using a primary CHROMagar screen.
by using phenotypic characteristics has led researchers to investigate more reliable methods for proper differentiation of these isolates (15, 17) and dictates the use of a combination of mycological, biochemical, and molecular techniques to unequivocally identify C. dubliniensis (2, 7, 13, 16, 18) .
C. dubliniensis has been reported to produce a distinctive dark green color on CHROMagar Candida (15) . However, this atypical color may not persist after serial passage of the organism and may be less useful for identifying isolates (16) . In the present study, atypical yeast isolates were prospectively identified by serial evaluation of primary CHROMagar Candida cultures from HIV-infected patients with OPC in San Antonio, Tex. These atypical isolates were then screened for C. dubliniensis by using phenotypic and genotypic assays, and the identification and prevalence of C. dubliniensis in this population was established.
Little information is available on susceptibility patterns of clinical isolates of C. dubliniensis. Fluconazole susceptibility testing by a modified microbroth dilution method on 20 C. dubliniensis isolates, including 15 oral isolates from HIV-infected patients, demonstrated MICs ranging from Յ1 to 32 g/ml, with MICs of Յ1 g/ml being determined for 80% of isolates tested (4) . In this study antifungal susceptibilities to amphotericin B and four azole agents were tested for one C. dubliniensis type strain and 22 clinical isolates of C. dubliniensis from HIV-infected patients with oropharyngeal candidiasis.
(This study was presented in part at the 98th General Meeting of the American Society for Microbiology, Atlanta, Ga., 17 to 21 May 1998 [abstract F48].)
RESULTS
Twenty-three of 63 (37%) HIV-infected patients had atypical, dark green colonies on CHROMagar Candida in 48 episodes of OPC. Colonies with light green color (Fig. 1 , left side of plate) were considered typical for C. albicans, whereas those with a dark green color on primary isolation were initially considered atypical C. albicans (Fig. 1 , right side of plate) and were subjected to further investigation.
Results of other phenotypic and genotypic identification assays are shown in Table 1 . All isolates produced germ tubes.
Abundant chlamydoconidium production was seen in only 17 of 51 (33%) isolates. Overall, of the isolates ultimately identified as C. dubliniensis (see below), 16 of 23 (70%) had abundant chlamydoconidium production, indicative of C. dubliniensis, while only 1 of 28 (4%) of those identified as C. albicans had abundant chlamydoconidium production (Table 1) . With API 20C, 25 of 28 (89%) C. albicans isolates were identified as C. albicans, while 8 of 23 (35%) C. dubliniensis isolates were misidentified as C. albicans (Table 1) . Xylose utilization was negative in all 23 isolates identified as C. dubliniensis and was positive in all 28 C. albicans strains. A total of 42 of 51 (82%) isolates were positive for fluorescence (with illumination at 365 nm) on methyl-blue 93 Sabouraud dextrose agar. Fluorescence was seen in 25 of 28 (89%) C. albicans isolates and in 17 of 23 (74%) C. dubliniensis isolates (Table 1) .
Differential temperature growth is shown in Table 1 . Fifty of 51 (98%) isolates grew well at 37°C. Very poor or no growth occurred at 42 and 45°C in 22 of 51 (43%) and 33 of 51 (65%) isolates, respectively. One isolate grew poorly at all temperature settings. Twenty-eight of 29 (97%) isolates that grew well at 42°C showed good hybridization of the moderately repetitive Ca3 probe with genomic DNA, indicative of C. albicans (Fig. 2) . All 22 isolates with negligible growth at 42°C and 1 strain with growth at 42°C showed weak hybridization of genomic DNA with the Ca3 probe, consistent with C. dubliniensis identification. All 23 C. dubliniensis strains demonstrated negligible or no growth at 45°C, but growth was seen in only 18 of 28 (64%) C. albicans isolates.
Overall, 22 clinical C. dubliniensis isolates were identified from 11 of 63 (17%) serially evaluated patients. C. dubliniensis was associated with infection in 16 of 22 episodes but was detected on surveillance cultures from the remaining 6 episodes. Isolation occurred after 2.9 Ϯ 0.2 episodes (mean Ϯ standard error; range, 1 to 8), although isolation occurred in the initial episode for five patients. Isolation of C. dubliniensis occurred in mixed yeast cultures including C. albicans and other yeasts in 11 of 22 (50%) cases (Table 2) . Antifungal susceptibility testing was performed on the 22 isolates plus a C. dubliniensis type strain according to the National Committee for Clinical Laboratory Standards method M-27A with amphotericin B, fluconazole, itraconazole, voriconazole, and SCH 56592 (Table 2) . Isolates were all susceptible to amphotericin B, with the MIC for 16 of 23 isolates being 0.125 g/ml (range 0.125 to 0.5 g/ml) at 48 h. The azoles demonstrated a wide range of MICs. Fluconazole MICs ranged from Յ0.125 to 64 g/ml.
The results for the other azoles were as follows: SCH 56592, MICs of Յ0.03 to 0.5 g/ml; itraconazole, MICs of Յ0.03 to 1 g/ml; and voriconazole, MICs of Յ0.125 to 2 g/ml. Two isolates were resistant to fluconazole (MICs of 64 g/ml at 48 h), and one showed dose-dependent susceptibility (MIC ϭ 16 g/ml). MICs of the other azoles for these isolates were lower: SCH 56592, MICs of 0.25 to 0.5 g/ml; itraconazole, MICs of 0.25 to 1 g/ml; and voriconazole, MICs of 0.5 to 2 g/ml. 
DISCUSSION
Although C. dubliniensis has been reported in association with oropharyngeal infection from patients in the United States (13), the prevalence and antifungal susceptibility of C. dubliniensis from patients in the United States has not been reported. In this study, the detection and prevalence of C. dubliniensis was established in a cohort of patients from San Antonio, Tex., with recurrent OPC and advanced AIDS who were serially evaluated. The prevalence of C. dubliniensis in this population was similar to that reported in HIV-infected patients in Ireland (32%) and confirms the widespread geographic distribution of this species (1, 17) . However, it should be noted that the 22 clinical C. dubliniensis isolates identified in this study represent Ͻ1% of the more than 5,500 isolates collected from these 63 patients in this ongoing serial evaluation (9, 10), suggesting that these isolates appear to remain uncommon in HIV-infected patients with oropharyngeal infection.
Isolates were screened for further study by selecting for atypical, dark green color on primary CHROMagar Candida cultures. Variable results using CHROMagar Candida to identify C. dubliniensis have been reported (15, 16) , which may be due to the fact that color may vary after serial passage. In this study, 22 of 48 (46%) clinical isolates initially considered to be atypical C. albicans were subsequently identified as C. dubliniensis. Since only atypical C. albicans isolates were screened for this study, it is possible that the reported prevalence could be an underestimate of the true prevalence in this population. However, more than 50 typical light green CHROMagar Candida isolates were confirmed to be C. albicans by phenotypic assays and the Ca3 probe in other studies (data not shown). These results suggest that primary isolation of atypical C. albicans colonies on chromogenic media could be used as a screening assay for additional identification studies.
Phenotypic assays demonstrated variable utility in identifying C. dubliniensis, but trends appear to exist. The use of chlamydoconidium production to identify C. dubliniensis isolates produced highly variable results and did not fully distinguish these isolates. However, of the isolates identified as C. dubliniensis, 16 of 23 (70%) had abundant chlamydoconidium production, indicative of C. dubliniensis, whereas only 1 of 28 (4%) of those identified as C. albicans had abundant chlamydoconidium production. In addition, most isolates tested were positive for fluorescence, which stands in contrast to data presented by Schoofs et al. (15) albicans, only 3 of 28 (11%) did not fluoresce. Variability in the results obtained by using these phenotypic methods limit their utility for identifying these isolates. API 20C was useful only when identification was confirmed as C. albicans. Fifteen of 23 (65%) of the isolates subsequently identified as C. dubliniensis were assigned "no ID" by API 20C, yet only 3 of 28 (11%) isolates identified as C. albicans by the Ca3 probe hybridization were not identified by API 20C. However, as reported by Salkin and colleagues previously (13) , xylose assimilation was present in all 28 C. albicans isolates and in none of the 23 C. dubliniensis isolates. However, expense prohibits the routine use of API 20C in identifying germ tubepositive yeasts.
Differential temperature was useful in distinguishing C. albicans from C. dubliniensis. At 42 and 45°C, C. dubliniensis demonstrated negligible or no growth. All isolates identified as C. albicans grew well at 37 or 42°C. All twenty-two (100%) isolates with negligible growth at 42°C and one with growth at 42°C were confirmed as C. dubliniensis by using the Ca3 probe. However, in this study it should be noted that C. albicans did not grow as well at 42°C and that slight growth of C. dubliniensis can occur at 42°C, although growth was significantly reduced compared to that of C. albicans.
Pinjon and colleagues showed that all C. dubliniensis strains tested failed to grow at 45°C compared to growth of all but one strain of C. albicans at that temperature (7) . However, in the present study, while none of the C. dubliniensis strains grew at 45°C, only 18 of 28 (64%) C. albicans isolates grew at that temperature, indicating that as a screening method, 45°C would falsely suggest the presence of C. dubliniensis in some cases.
Identification of C. albicans and C. dubliniensis was confirmed with fingerprinting of genomic DNA with the Ca3 probe. Twenty-eight of 29 isolates that grew well at 42°C had distinct hybridization patterns characteristic of C. albicans while 22 of 22 (100%) of the isolates that grew poorly at 42°C hybridized poorly and in a distinctive pattern, indicative of C. dubliniensis. Probes have recently been developed which are specific for C. dubliniensis, although use of these methods would be limited to a research setting (2, 3) .
Although the pathogenicity of this yeast has not been established, C. dubliniensis was associated with clinical oropharyngeal infection in 16 of 22 (73%) cases and was present as the sole yeast isolate in 11 of 22 (50%) episodes. Risk factors and significance of this organism in oropharyngeal disease have also not been established. Isolation frequently occurred after several episodes of oropharyngeal infection but was found in the initial episode of oropharyngeal infection in five patients. Most strains remained susceptible to fluconazole although resistance or dose-dependent susceptibility occurred for three isolates. Increased susceptibility for the resistant strains was seen with itraconazole and the newer azoles, voriconazole and SCH 56592. Some isolates are resistant to fluconazole and may be more susceptible to other azole compounds.
In summary, the presence of atypical colonies on primary CHROMagar Candida cultures was used to identify isolates for further study. Differential temperature screening was extremely useful as a simple and inexpensive method for presumptively identifying C. dubliniensis from atypical C. albicans isolates for additional molecular studies (7) . Twenty-two clinical isolates from 48 episodes of OPC in 63 patients were confirmed as C. dubliniensis by using a primary CHROMagar screening method followed by differential temperature growth and molecular studies to establish identity. Late-stage HIVinfected patients were found to have a C. dubliniensis prevalence rate of 17% in oropharyngeal samples by this approach.
These isolates may show decreased susceptibility to fluconazole and may have increased susceptibility to newer azoles. Additional studies are needed to establish the epidemiology and significance of this organism in recurrent OPC.
